PMID: 6407041Jan 1, 1983Paper

Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice

Psychopharmacology
K KiianmaaB Tabakoff

Abstract

The effects of naltrexone on the increase in locomotor activity induced by a low dose (1.35 g/kg IP) of ethanol and on the duration of loss of righting reflex after a high dose (3.5 g/kg) of ethanol were studied in BALB/c, DBA/2, and C57BL/6 mice. Ethanol increased locomotor activity in DBA and BALB mice, but not in C57BL mice. Naltrexone, at a dose of 0.1 mg/kg, antagonized the ethanol-induced increase in locomotion similarly in DBA and BALB mice. The duration of loss of righting reflex was, however, differentially affected in all three strains by naltrexone. The BALB mice affected in all three strains by naltrexone. The BALB mice were the most sensitive strain (1 mg/kg naltrexone significantly counteracted ethanol hypnosis), the C57BL mice were intermediate (8 mg/kg naltrexone required to antagonize this effect of ethanol), and the DBA mice were least sensitive (no effect evident even at the highest dose of 8 mg/kg) to naltrexone. Thus, naltrexone could antagonize the behavioral effects of a low and high dose of ethanol, but the three strains, which differ in their behavioral response to ethanol, also were differentially sensitive to the effect of naltrexone in reversing ethanol-induced hypnosis and ethanol-induced changes in...Continue Reading

References

Oct 23, 1978·Life Sciences·A Horita, M A Carino
Mar 31, 1979·Lancet·A I Mackenzie
Dec 1, 1979·Lancet·W J JeffcoateC P Walder
Nov 5, 1979·Life Sciences·J SawynokF S LaBella
Jan 1, 1975·Annual Review of Pharmacology·H W Kosterlitz, A A Waterfield
Jan 1, 1979·Drug and Alcohol Dependence·G E McClearn, S M Anderson
Dec 2, 1978·British Medical Journal·R D Leslie, D A Pyke
Jun 1, 1976·Biochemical Pharmacology·B TabakoffR F Ritzmann
Jun 12, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·A CarlssonB Waldeck
May 25, 1972·Annals of the New York Academy of Sciences·G E McClearn
Feb 9, 1980·Lancet·D B JefferysG N Volans
Apr 1, 1982·Pharmacology, Biochemistry, and Behavior·C Castellano, S Puglisi-Allegra
Jan 1, 1981·Psychopharmacology·D M CatleyJ G Jones
Nov 1, 1981·British Journal of Pharmacology·A A Badawy, M Evans

❮ Previous
Next ❯

Citations

Jan 1, 1994·Life Sciences·T SeppäläM J Mattila
Dec 1, 1983·Pharmacology, Biochemistry, and Behavior·J D SindenJ Le Magnen
Jan 1, 1985·Pharmacology, Biochemistry, and Behavior·H H Samson, T F Doyle
Jul 1, 1987·Pharmacology, Biochemistry, and Behavior·L D MiddaughC L Randall
Oct 1, 1989·Pharmacology, Biochemistry, and Behavior·L D MiddaughW O Boggan
Oct 1, 1992·Pharmacology, Biochemistry, and Behavior·L D MiddaughC L Shepherd
Jan 1, 1988·Pharmacology & Therapeutics·L A Pohorecky, J Brick
Sep 1, 1984·Peptides·G A OlsonA J Kastin
Jun 26, 1987·Neuroscience Letters·P M Laduron, P A De Witte
Jan 1, 1991·General Pharmacology·A OrtsM M Puig
Jan 1, 1989·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·T PelissierC Paeile
Jun 29, 2004·Behavioural Brain Research·Carla Sanchis-SeguraCarlos M G Aragon
Dec 5, 2002·European Journal of Pharmacology·Taleen HananiaNancy R Zahniser
Feb 1, 1988·Pharmacological Research Communications·K PrabakaranE R Shanmugasundaram
Sep 6, 2000·Pharmacology, Biochemistry, and Behavior·M C MhatreF A Holloway
May 1, 1997·Pharmacology, Biochemistry, and Behavior·A D LêE M Sellers
Sep 17, 1998·Pharmacology, Biochemistry, and Behavior·D LyonsL J Porrino
Nov 21, 2001·Drug and Alcohol Dependence·M CorreaC M Aragon
Sep 18, 2002·Drug and Alcohol Dependence·Carla Sanchis-Segura, Carlos M G Aragon
Aug 1, 1994·Alcoholism, Clinical and Experimental Research·L Williams-Hemby, L J Porrino
Dec 1, 1994·Alcoholism, Clinical and Experimental Research·J P de WaeleC Gianoulakis
Apr 9, 1999·Alcoholism, Clinical and Experimental Research·L D MiddaughC H Groseclose
Jan 1, 1988·Neurochemistry International·H OllatS Parvez
Aug 1, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Wade Berrettini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.